AAM
ELV icon

Aureus Asset Management’s Elevance Health ELV Stock Holding History

Aureus Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-101,193
Closed -$14.1M – 134
2016
Q1 		$14.1M Buy
101,193
+2,070
+2% +$277K 3.07% 6
2015
Q4 		$13.8M Buy
99,123
+11,625
+13% +$1.6M 3.1% 7
2015
Q3 		$12.3M Buy
87,498
+7,879
+10% +$1.18M 3.05% 8
2015
Q2 		$13.1M Buy
79,619
+1,792
+2% +$286K 2.75% 2
2015
Q1 		$12M Buy
77,827
+2,421
+3% +$345K 2.76% 2
2014
Q4 		$9.48M Buy
+75,406
New +$9.32M 2.3% 16

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Aureus Asset Management's ELV Position: Q2 2016 in Review

Aureus Asset Management sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 101,193 shares — an estimated $14.1M sold.

Aureus Asset Management first reported a position in ELV in Q4 2014 and held it in 6 quarters. The position peaked at $14.1M in Q1 2016. 759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

  • Aureus Asset Management reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
  • Aureus Asset Management sold 101,193 Elevance Health shares in Q2 2016, an estimated $14.1M.
  • Aureus Asset Management first reported a position in Elevance Health in Q4 2014 and held it in 6 quarters.
  • Aureus Asset Management's Elevance Health position peaked at $14.1M in Q1 2016.
  • 759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Aureus Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.